is in the UK, India may be the next country to approve mass vaccination against the new crown.
Reuters quoted the Press Trust of India (PTI) as reporting that as the world’s largest vaccine manufacturer (by scale), the Serum Institute of India seeks an emergency response to the British AstraZeneca pharmaceutical company’s new crown vaccine in India on the 6th. Use authorization.
The Press Trust of India quoted official sources as saying that the institute filed an application with the Drug Administration of India, stating that the medical needs caused by the new crown pandemic could not be met. For the benefit of the general public, it hopes to give AstraZeneca Pharmaceuticals Emergency use authorization for the company's new crown vaccine in India. The Serum Institute of India has not yet responded to this matter. In addition, on the 5th, Pfizer Pharmaceuticals of the United States applied for an emergency use authorization for its new crown vaccine in India. Pfizer told Reuters: “We are still committed to negotiating with the Indian government to seek opportunities for the use of this vaccine in India.”
reported that the Indian Serum Institute’s application stated that there were four people from the UK, Brazil and India. Data from a clinical study shows that this vaccine is very effective in preventing serious infections of new coronary pneumonia. In addition, the sale of AstraZeneca's vaccine in India is feasible because its storage temperature is 2 to 8 degrees Celsius.
